Connect with us
MARE BALTICUM Gaming & TECH Summit 2024

Artificial Intelligence

Global Asthma Spacer Market is Estimated to Grow at a CAGR Of 5.8% During the Estimated Time Frame from 2021 to 2030; Quince Market Insights

Published

on

Pune, India, Jan. 07, 2022 (GLOBE NEWSWIRE) — The global asthma spacer market was estimated to value USD 1,367.04 million in 2021 and is projected to grow at a CAGR of 5.8% during the forecast period, as per a recent comprehensive market study by Quince Market Insights. A spacer is an empty tube with a holding chamber that is usually made of plastic. It makes it easier to take asthma or chronic obstructive pulmonary disease (COPD) medication from a puffer, known as an MDI (metered-dose inhaler). Spacers direct medicine to the lungs, resulting in less medication ending up in the mouth and throat, where it can cause irritation or mild infections. A spacer can also help coordinate breathing and puffing.

Get Sample Copy of This Report @ https://www.quincemarketinsights.com/request-sample-74394

Asthma is the most common chronic respiratory disease globally, and this leads to an increase in the use of spacers. Growing geriatric population and increasing pollution are the key factors that contribute to the growth of asthma cases. Further, respiratory disorders are likely to increase among the geriatric population due to their weak immune system’s response to inflammation. Children with asthma may face various challenges during the use of inhalers or mouthpiece for the proper management of the condition. For instance, they may be unable to hold their breath while using inhalers. As a result, spacers are more commonly used for younger children as compared to adults.

The elderly population also finds it difficult to use inhaler devices effectively, due to which asthma spacers are widely used for the geriatric population. Various market players operating in spacers market are developing spacers for use of children and elders.

Respiratory conditions like asthma, chronic obstructive pulmonary disease (COPD), and others have common signs like shortness of breath, chest tightness, wheezing, and coughing. Many people don’t realize these common symptoms, along with other symptoms like trouble sleeping and persistent cough, which reduces the chances of seeking treatment. Furthermore, the adult-onset asthma develops during childhood but can arise at any age, which is a major factor in causing low awareness about the disease.

Furthermore, the lack of community awareness is another major factor that is restraining the asthma spacer’s market growth in developing and low-income countries. People fail to understand the severity of asthma due to the stigma and myths associated with the condition in some regions, for which the disease remains undiagnosed or underdiagnosed in many places.

Impact of COVID-19 Pandemic

The impact of the pandemic on the healthcare sector has been negative. People with respiratory diseases are more vulnerable, as coronavirus primarily affects or damages the respiratory system, thereby lowering the supply of oxygen in the body. As a result, the respiratory devices industry has been growing at the fastest rate. As the number of COVID-19 patients grows, so does the demand for respiratory devices.

Market Segmentation

By Spacer Type

Based on the spacer type, the global asthma spacer market has been divided into volumatic, aerochamber, inspirease, optichamber, and others (VORTEX, Zerostat -V Spacer, babyhaler, A2A Spacer, and asthma spacers). The aerochamber segment is expected to hold a fastest growing market share during the predicted period. Due to the broad adoption of these devices for asthma management. Technological developments in aerochambers are expected to drive the segment during the predicted period.

By Type

On the basis of type, the asthma spacers market is bifurcated into single-use and reusable type. The single use type of asthma spacer is anticipated to be the fastest growing segment the market. Single-use asthma spacers are easy to use, of low cost and recyclable. These single use spacers are easy to assemble for asthma patients and suitable for children and adults. The raw materials used for single-use spacers are cardboard or plastic. This type of spacers are used for one time to avoid the cross contamination and spread of infection. In the COVID-19 pandemic situation, the single-use asthma spacer has witnessed significant growth to avoid the spread of infection.

By Material

On the basis of material, the market is bifurcated into plastic and paper. Between these two segments, the plastic segment is anticipated to be the fastest growing segment in the market. The performance of asthma spacers vary according to the material used in manufacturing. Moreover, the properties of spacers, such as susceptibility to electrostatic charge, depend on the material used in manufacturing asthma spacers. The growing use of non-valved homemade spacers manufactured from various types of materials is expected to fuel the growth of the segment.

By Distribution Channel

Based on the distribution channel, the asthma spacers market has been bifurcated into hospital pharmacies, retail pharmacies, and online pharmacies. Retail pharmacies are anticipated to be the fastest growing segment in the asthma spacer market during the projected period. They are privately-owned, medicine-dispensing centers registered with the state authorities.

Retail pharmacies offer prescription as well as over-the-counter medicines. Retail pharmacies also guide patients or customers with the usage of medications and medical products. These pharmacies are in contact with original equipment manufacturers and hospitals to provide medical products, which will further drive the asthma spacer’s demand.

Moreover, most low- or middle-income people are unable to visit hospitals and are, therefore, more inclined towards these pharmacies. This will drive the retail pharmacy segment for asthma spacers.

Enquiry Before Buying This Report @ https://www.quincemarketinsights.com/enquiry-before-buying/enquiry-before-buying-74394

By Region

In the asthma spacer market, there are five major regions, including North America, Europe, Asia Pacific, Middle East & Africa, and South America. North America is the fastest growing segment in the market. Increasing prevalence of asthma and a rise in government initiatives that mandate the utilization of asthma spacers with metered-dose inhalers are increasing the demand for asthma spacers in this zone.

Recent Developments in the Asthma Spacer Market

  • April 2021 Vyaire Medical Inc. (U.K) had declared the European launch of ArtiQ.PFT, an automated tool operated by artificial intelligence that immediately interprets pulmonary function tests (PFTs). The technology’s algorithm identifies disease patterns in 82% of cases as compared to 45% by pulmonologists, as per the multi-center study published in the European Respiratory Journal.
  • April 2019 Cipla Inc. (India) announced the launch of the first extra-fine particle beclomethasone-formoterol combination hydrofluoroalkane (HFA) inhaler, Niveoli. The product is the latest offering from Cipla’s respiratory inhalation therapy that addresses obstructive airway diseases (OAD) like asthma and chronic obstructive pulmonary disorder (COPD).

Major companies operating in the global market, which include Trudell Medical Internationa (London), Pari Gmbh (Germany), GlaxoSmihKline plc (U.K), Medical Development International (Australia), Cipla (India), Lupin (India), Clement Clarke (U.K).

To find more insights on this topic, visit Quince Market Insights report titled, “Asthma Spacers Market, by Product Type (Aerochamber, Optichamber, Volumatic, InspirEase, Others), Type (Reusable, Single Use) Material Type (Plastic, Paper), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), Region (North America, Europe, Asia Pacific, Middle East & Africa, South America)” in-depth analysis along with the table of contents (ToC).

Buy Now Full Report @ https://www.quincemarketinsights.com/insight/buy-now/asthma-spacer-market/single_user_license

Contact Us:
Ajay D
Quince Market Insights
Pune India
Phone: US +1 208 405 2835
UK +44 1444 39 0986
APAC +91 706 672 4848
Email: [email protected]
Web: www.quincemarketinsights.com

Browse Related Reports:

Respiratory Care Devices Market, By Product (Therapeutic (Ventilator, Mask, PAP Device, Inhaler, Nebulizer), Monitoring (Pulse Oximeter, Capnograph), Diagnostic, Consumables), By End User (Hospital, Home Care), By Indication (Chronic Obstructive Pulmonary Disease (COPD), Asthma, Sleep Apnea, Infectious Disease), By Region (North America, Eastern Europe, Western Europe, Asia Pacific, Middle East, Rest of the World) – Market Size & Forecasting (2016-2028)

https://www.quincemarketinsights.com/industry-analysis/respiratory-care-devices-market

Oxygen Therapy Equipment Market, By Product (Oxygen Source (Concentrator, Cylinder), Delivery Devices), By Portability (Stationary, Portable), By Application (COPD, Asthma, Cystic Fibrosis, Pneumonia), By End User (Hospital, Home Care), By Region (North America, Eastern Europe, Western Europe, Asia Pacific, Middle East, Rest of the World) – Market Size & Forecasting (2016-2028)

https://www.quincemarketinsights.com/industry-analysis/oxygen-therapy-equipment-market

Asthma Therapeutics Market, By Drug (Anti- Inflammatory, Bronchodilators, Combination Therapy), Device (Inhalers, Dry Powder, Metered Dose, Soft Mist, Nebulizers), Route Of Administration (Oral, Inhale, Intravenous, Subcutaneous), and By Region (North America, Western Europe, Eastern Europe, Asia Pacific, Middle East, and the Rest of the World) – Market Size & Forecasting (2017-2028)

https://www.quincemarketinsights.com/industry-analysis/asthma-therapeutics-market

Portable Oxygen Concentrators Market, By Product (Pulse Flow, Continuous Flow), By Indication (Chronic Obstructive Pulmonary Disease (COPD), Asthma, Sleep Apnea), By End user (Homecare, Travel, Hospital, Others), By Region (North America, Eastern Europe, Western Europe, Asia Pacific, Middle East, Rest of the World) – Market Size & Forecasting (2016-2028)

https://www.quincemarketinsights.com/industry-analysis/portable-oxygen-concentrators-market

GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Artificial Intelligence

Synthetik Applied Technologies LLC announces development of UrbanScale – a modeling platform for the prediction, characterization, and quantification of extreme urban heat

Published

on

synthetik-applied-technologies-llc-announces-development-of-urbanscale-–-a-modeling-platform-for-the-prediction,-characterization,-and-quantification-of-extreme-urban-heat

AUSTIN, Texas and LONDON, April 30, 2024 /PRNewswire/ — Synthetik Applied Technologies announces the development of UrbanScale, a tool to model and predict effects of extreme heat in urban areas, through a project funded by the National Oceanic and Atmospheric Association (NOAA). The physical characteristics of urban areas amplify heat effects resulting in what are known as urban heat islands — areas where surface temperatures are much higher than their surroundings. The UrbanScale tool addresses this climate peril with sophisticated analytic tools based on physics informed neural networks and cutting-edge machine learning to predict urban heat and help better understand and mitigate the risks associated with these extreme heat events. As a result of climate change, these events are expected to increase, impacting both the people that live in urban areas and the infrastructure on which they depend.

The UrbanScale platform shows significant promise to provide data on the severity of heat islands and their effects to better understand how they impact human health, energy use and damage to physical infrastructure. This information will provide a step-change in capability for government agencies, urban planners, and transportation authorities to direct efforts for mitigation and intervention. In particular, inclusion of demographic information into data pipelines will allow understanding of how urban heat effects may impact vulnerable or disadvantaged populations. Integration with climate forecasts and models will also provide unprecedented capabilities for forecasting risk associated with climate change.
Josh Hatfield, Director of Research and Development at Synthetik, said:
‘We are extremely grateful for the opportunity to study such an important issue. Extreme heat is already the largest cause of weather-related fatalities in the US, and climate change will only increase the importance of understanding heat in urban environments. Helping to meet that challenge fits directly into Synthetik’s mission.’
Synthetik COO Tim Brewer commented:
‘The UrbanScale tool will allow both our government and insurance partners to better characterize the risk of extreme heat in urban centers and promises to deliver critical insight on the way these events impact energy demands. We look forward to exploring its wide-ranging applications.’
Synthetik plans further development of UrbanScale with NOAA and other partners in the public and private sector.
For all inquiries: Contact Synthetik Applied Technologies PR [email protected] 
Logo – https://mma.prnewswire.com/media/2067510/Synthetik_Applied_Technologies_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/synthetik-applied-technologies-llc-announces-development-of-urbanscale–a-modeling-platform-for-the-prediction-characterization-and-quantification-of-extreme-urban-heat-302132016.html

Continue Reading

Artificial Intelligence

GLiNTECH – a Valiantys company, wins Atlassian Partner of the Year 2023 Services (APAC) award. Valiantys and GLiNTECH declared Finalists for Team Excellence and ITSM Solutions

Published

on

glintech-–-a-valiantys-company,-wins-atlassian-partner-of-the-year-2023-services-(apac)-award.-valiantys-and-glintech-declared-finalists-for-team-excellence-and-itsm-solutions

PARIS, April 30, 2024 /PRNewswire/ — Atlassian announced today that GLiNTECH – a Valiantys company has won the Atlassian Partner of the Year 2023 Services (APAC) award. Valiantys and GLiNTECH were further declared finalists for the Team Excellence and ITSM Solutions awards, respectively.

 
This is an acknowledgement of their outstanding work for Atlassian customers during the calendar year 2023. This includes exceptional efforts in developing new business and driving innovative solutions for customer success.
“Our industry leading partners play a vital role in our customers’ continued success. We’re honored to highlight our top partners as award finalists this year, reflecting their ongoing commitment to delivering innovative solutions and unparalleled Atlassian services globally,” said Ko Mistry, Atlassian’s Head of Global Channels.
“We are delighted to be named as finalists for these awards from Atlassian, and we are particularly proud to celebrate GLiNTECH’s achievement in winning the Services (APAC) award.” said Emmanuel Benoit, Global Chief Executive Officer, Valiantys. “At Valiantys, embracing diversity of thought and challenging the ways our teams work has always provided Valiantys with a competitive edge to consistently deliver tangible results and value. We look to the future with unwavering determination and confidence as we continue to drive innovation and unlock potential for our customers around the globe.”
“We dedicate our IT Consulting Services and Custom Solutions to fulfilling our customers’ needs for success,” commented Dimitri Spyridopoulos, Chief Executive Officer GLiNTECH – a Valiantys company. “It’s an honor to be recognized by Atlassian as a finalist in two categories that reflect these efforts: Services and ITSM Solutions, and to be declared as winner for the Services award (APAC).”
For more information regarding this Press Release, contact: [email protected]
About Valiantys
Valiantys is a leading global consulting and services firm dedicated to Atlassian. The company accelerates business transformation by digitizing processes and modernizing teamwork, using the best agile methods and tools. Its Atlassian technical expertise is unparalleled and Valiantys supports its customers across the entire spectrum of projects on those platforms. As a recognized Agile at Scale, ITSM, and Cloud Specialized Partner, Valiantys help organizations accelerate time to value with Agile at scale, cloud, and ITSM implementations. Because teamwork requires more than just tools, the firm bridges the gap between applications and strategic practices such as SAFe® and ITIL. Over the last 15 years, Valiantys has helped more than 5,000 customers achieve their desired business outcomes at a reduced time to value, through improved team collaboration. More information about Valiantys can be found at https://www.valiantys.com/
About GLiNTECH – a Valiantys Company
GLiNTECH is a renowned Atlassian Platinum Partner headquartered in Australia and is the preferred choice for over 300 leading brands. The company has amassed more than 20 years of experience servicing enterprise clients across the Asia Pacific region, earning Atlassian Partner of the Year five times, including most recently for Professional Services. GLiNTECH is recognized as a Specialized Atlassian Cloud and ITSM partner. The company offers deep expertise in Licensing, Training, Support, Managed Services, Consulting, and Agile methodologies and has a proven record in providing reliable solutions while driving success within the Atlassian ecosystem. More information about GLiNTECH can be found here: https://www.glintech.com/
GLiNTECH was acquired by Valiantys in February 2024.
Photo – https://mma.prnewswire.com/media/2397508/GLiNTECH_2023_Services_award.jpg Logo – https://mma.prnewswire.com/media/1980997/Valiantys_Logo.jpg
 

View original content:https://www.prnewswire.co.uk/news-releases/glintech—a-valiantys-company-wins-atlassian-partner-of-the-year-2023-services-apac-award-valiantys-and-glintech-declared-finalists-for-team-excellence-and-itsm-solutions-302127386.html

Continue Reading

Artificial Intelligence

Nillion is pleased to announce that Dwinity, a team pioneering decentralized AI has joined as an ecosystem partner

Published

on

nillion-is-pleased-to-announce-that-dwinity,-a-team-pioneering-decentralized-ai-has-joined-as-an-ecosystem-partner

ZUG, Switzerland and MUNICH, April 30, 2024 /PRNewswire/ — With huge amounts of personal data being collected every day, privacy concerns are escalating as the impact of data breaches become more costly. The need to address the problems created by the existing data economy have never been greater. By empowering users to reclaim control, Dwinity aims to unlock an enormous amount of potential for personal data to enhance various industries like healthcare, insurance, and finance.

About Dwinity
Dwinity’s mission is to give power back to users and to create a thriving data economy in which information asymmetry is finally removed. Dwinity enables a decentralized data economy as well as creates a data ownership driven ecosystem for storage, analysis, exchange, and commercialization of sensitive personal data.
The three components of Dwinity are:
Data control: Decentralized data spaces for decentralized data storage which provides true data sovereignty and enables users to decide with whom data is shared.Data Gold: Decentralized AI tools for each data space have the capability to unlock the full potential of data via sophisticated analysis.Data Cash: A fair marketplace with automated data value analysis, allowing for tangible income for data owners at lower costs and completely anonymous.Dwinity is presently closing its initial seed round at USD 3 MN – funds which will be used for the development of the initial prototypes to hit the market already in 2024.
About Nillion
Nillion is humanity’s first Blind Computer. It is powered by a decentralized network of nodes that enables “Blind Computation” through the coordination and orchestration of privacy enhancing technologies (PETs) such as multi-party computation (MPC), fully homomorphic encryption (FHE) and zero-knowledge proofs (ZKP). Nillion believes Blind Computation will become the internet’s base layer for all private data as PETs continue to mature. Nillion has attracted a notable initial cohort of Blind Computation builders across AI, DeFi, medical data, custody, wallets, global identity, messaging and more.
The Nillion development company, Nilogy, was incubated by CoinList’s seed program. Nilogy’s Founding CTO was the Founding Engineer of Uber (Conrad Whelan), the Chief Strategy Officer was the Founding CMO of Hedera Hashgraph (Andrew Masanto), the Chief Business Officer is the Founder of Indiegogo (Slava Rubin), the General Counsel was the Associate General Counsel of Coinbase (Lindsay Danas Cohen), along with builders hailing from Consensys, LayerZero, Polygon and Google.
“This is a major step on our way to building the leading ecosystem for sensitive data together with one of the top players in the market for the handling of such valuable data. We are looking forward to the cooperation which will add significant trust and competence to both initiatives”, said Peter Koenig, CEO of Dwinity.
Picture is available at AP
Contact for this publication: Christian Mangold [email protected]

View original content:https://www.prnewswire.co.uk/news-releases/nillion-is-pleased-to-announce-that-dwinity-a-team-pioneering-decentralized-ai-has-joined-as-an-ecosystem-partner-302131972.html

Continue Reading
Advertisement
Advertisement

Latest News

Trending